Cancer outcomes in patients eligible for adjuvant cyclin-dependent kinase 4 and 6 inhibitors but spared adjuvant chemotherapy by Oncotype Dx: A multicenter retrospective GBECAM 0520 study
符合辅助细胞周期蛋白依赖性激酶 4 和 6 抑制剂治疗条件但因 Oncotype Dx 检测结果而未接受辅助化疗的患者的癌症预后：一项多中心回顾性 GBECAM 0520 研究
期刊:Breast
影响因子:7.9
doi:10.1016/j.breast.2025.104554
Oliveira, Leandro Jonata de Carvalho; Rosa, Daniela Dornelles; Katz, Artur; Assad-Suzuki, Daniele; Argolo, Daniel; Sanches, Solange Moraes; Testa, Laura; Bines, José; Kaliks, Rafael Aliosha; de Melo Gagliato, Debora; Barroso-Sousa, Romualdo; Corrêa, Tatiana Strava; Shimada, Andrea Kazumi; Dos Anjos, Carlos Henrique; Linck, Rudinei; Megid, Thais Baccili Cury; Batista, Daniel Negrini; Gomes, Daniel Musse; Cesca, Marcelle Goldner; Gaudêncio, Débora; Moura, Larissa Matos Almeida; Pereira de Araújo, Julio Antonio; Bonadio, Renata Colombo; Silva de Souza, Zenaide; Beal, Juliana Rodrigues; Lopes, Mario Machado; Sales, Leticia Telles; Parisi Marlière, Júlia Leal Franco; Mano, Max Senna
